Novo Nordisk's pricing approaches in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of rate gouging, mentioning the stark contrast amongst U.S. rates and those in Europe and copyright.Novo Nordisk is involved with government funded collaborative investigate tasks with other industrial and gove